Literature DB >> 34535589

IL-6 Is Associated with Progression of Coronary Artery Calcification and Mortality in Incident Dialysis Patients.

Neil Roy1,2, Sylvia E Rosas3,4.   

Abstract

INTRODUCTION: Inflammation is important in the pathogenesis of atherosclerosis. Elevated interleukin-6 (IL-6) is associated with cardiovascular events and also predicts mortality in individuals with CKD. Our goal was to determine the association between IL-6, FGF23, and high-sensitivity C-reactive protein (hsCRP) on coronary artery calcification (CAC) progression and mortality in incident dialysis patients without prior coronary events.
METHODS: A prospective cohort of incident adult dialysis participants had CAC measured by ECG-triggered multislice CT scans at baseline and at least 12 months later. Lipids, mineral metabolism markers, FGF23, and inflammatory markers, such as IL-6 and hsCRP, were measured at the baseline visit.
RESULTS: Participants in the high IL-6 tertile had the highest baseline CAC score (133.25 [10.35-466.15]) compared to the low (0.25 [0-212.2]) and intermediate (29.55 [0-182.85]) tertiles. Almost half of the participants with high IL-6 (15 of 32 [46.9%]) experienced progression of CAC compared to participants with low (8 of 32 [25%]) and intermediate (9 of 32 [28.1%]) (p = 0.05) IL-6 levels. Each log increase in IL-6 was associated with increase in death (hazard ratio 2.2, 95% CI: 1.2-3.8; p = 0.01). After adjusting for smoking, age, gender, race, diabetes, phosphate, and baseline calcium score, IL-6 (log) was associated with 2.2 times (95% CI: 1.1-4.6; p = 0.03) increase in death.
CONCLUSION: IL-6 is associated with progression of CAC and mortality in incident dialysis patients.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Coronary artery calcification; Dialysis; Fibroblast growth factor 23; High-sensitivity C-reactive protein; Interleukin-6

Mesh:

Substances:

Year:  2021        PMID: 34535589      PMCID: PMC8563392          DOI: 10.1159/000518652

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   4.605


  37 in total

1.  Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients.

Authors:  Ronney S Shantouf; Matthew J Budoff; Naser Ahmadi; Arshia Ghaffari; Ferdinand Flores; Ambarish Gopal; Nazanin Noori; Jennie Jing; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2010-04-09       Impact factor: 3.754

2.  Fibroblast growth factor-23 and cardiovascular events in CKD.

Authors:  Julia J Scialla; Huiliang Xie; Mahboob Rahman; Amanda Hyre Anderson; Tamara Isakova; Akinlolu Ojo; Xiaoming Zhang; Lisa Nessel; Takayuki Hamano; Juan E Grunwald; Dominic S Raj; Wei Yang; Jiang He; James P Lash; Alan S Go; John W Kusek; Harold Feldman; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2013-10-24       Impact factor: 10.121

3.  Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?

Authors:  Carmine Zoccali; Giovanni Tripepi; Francesca Mallamaci
Journal:  J Am Soc Nephrol       Date:  2006-12       Impact factor: 10.121

4.  IL 6 but not TNF is linked to coronary artery calcification in patients with chronic kidney disease.

Authors:  Joanna Kamińska; Marek Stopiński; Krzysztof Mucha; Anna Jędrzejczak; Marek Gołębiowski; Monika A Niewczas; Leszek Pączek; Bartosz Foroncewicz
Journal:  Cytokine       Date:  2019-04-13       Impact factor: 3.861

5.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Authors:  J Zimmermann; S Herrlinger; A Pruy; T Metzger; C Wanner
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

6.  Influence of preventive therapy with quinapril on IL-6 level in patients with chronic stable angina.

Authors:  Magdalena Gibas; Jolanta Miszczak-Smiałek; Edyta Madry; Jerzy Głuszek; Henryk Witmanowski; Janusz Piotrowski
Journal:  Pharmacol Rep       Date:  2007 May-Jun       Impact factor: 3.024

7.  Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis.

Authors:  Hae Hyuk Jung; Sang-Wook Kim; Heon Han
Journal:  Nephrol Dial Transplant       Date:  2006-03-22       Impact factor: 5.992

8.  Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.

Authors:  Jia Sun; Jonas Axelsson; Anna Machowska; Olof Heimbürger; Peter Bárány; Bengt Lindholm; Karin Lindström; Peter Stenvinkel; Abdul Rashid Qureshi
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-08       Impact factor: 8.237

9.  Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment.

Authors:  Roberto Pecoits-Filho; Peter Bárány; Bengt Lindholm; Olof Heimbürger; Peter Stenvinkel
Journal:  Nephrol Dial Transplant       Date:  2002-09       Impact factor: 5.992

10.  FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients.

Authors:  Abdullah Ozkok; Cigdem Kekik; Gonca Emel Karahan; Tamer Sakaci; Alper Ozel; Abdulkadir Unsal; Alaattin Yildiz
Journal:  BMC Nephrol       Date:  2013-11-01       Impact factor: 2.388

View more
  3 in total

1.  SOD3 and IL-18 Predict the First Kidney Disease-Related Hospitalization or Death during the One-Year Follow-Up Period in Patients with End-Stage Renal Disease.

Authors:  Yu-Hsien Liu; Yu-Hsuan Chen; Chi-Hua Ko; Chia-Wen Kuo; Chih-Ching Yen; Wei Chen; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Antioxidants (Basel)       Date:  2022-06-18

Review 2.  The Role of Interleukin-6 Family Members in Cardiovascular Diseases.

Authors:  Yongqi Feng; Di Ye; Zhen Wang; Heng Pan; Xiyi Lu; Menglong Wang; Yao Xu; Junping Yu; Jishou Zhang; Mengmeng Zhao; Shuwan Xu; Wei Pan; Zheng Yin; Jing Ye; Jun Wan
Journal:  Front Cardiovasc Med       Date:  2022-03-23

3.  Bee gomogenat rescues lymphoid organs from degeneration by regulating the crosstalk between apoptosis and autophagy in streptozotocin-induced diabetic mice.

Authors:  Gamal Badr; Leila H Sayed; Hossam El-Din M Omar; Sary Khaleel Abd Elghaffar; Medhat M Menshawy
Journal:  Environ Sci Pollut Res Int       Date:  2022-05-13       Impact factor: 5.190

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.